Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

Patients Treated for Wiskott-Aldrich Syndrome (WAS) Since 1990

ClinicalTrials.gov ID: NCT02064933

Public ClinicalTrials.gov record NCT02064933. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 3:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Analysis of Patients Treated for Wiskott-Aldrich Syndrome Since January 1, 1990 (RDCRN PIDTC-6904)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Wiskott - Aldrich syndrome (WAS) is a rare serious medical condition that causes problems both with the immune system and with easy bruising and bleeding. The immune abnormalities cause patients with WAS to be very susceptible to infections. Depending on the specific type of primary immune deficiency diseases, there are effective treatments, including antibiotics, cellular therapy and gene therapy, but studies of large numbers of patients are needed to determine the full range of causes, natural history, or the best methods of treatment for long term success. This multicenter study combines retrospective, prospective and cross-sectional analyses of the transplant experiences for patients with WAS who have already received HCT since 1990, or who will undergo Hematopoietic cell transplant (HCT) during the study period. The retrospective and prospective portions of the study will address the impact of a number of pre and post-transplant factors on post-transplant disease correction and ultimate benefit from HCT and the cross-sectional portion of the study will assess the benefit of HCT 2 years post-HCT in consenting surviving patients.

Study identification

NCT ID
NCT02064933
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Enrollment
305 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
Not listed
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2, 2014 (Actual)
Primary completion
May 1, 2019 (Actual)
Completion
May 1, 2019 (Actual)
Last update posted
Aug 10, 2020

2014 – 2019

United States locations

U.S. sites
38
U.S. states
25
U.S. cities
36
Facility City State ZIP Site status
Department of Pediatrics, University of Alabama at Birmingham Birmingham Alabama 35233 —
Phoenix Children's Hospital Phoenix Arizona 85016 —
Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California Los Angeles California 90027 —
Department of Pediatrics, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles California 90095-1752 —
Lucile Salter Packard Children's Hospital at Stanford Palo Alto California 94304 —
University of California, San Francisco Benioff Children's Hospital San Francisco California 94143-1278 —
Children's Hospital Denver, University of Colorado Denver Colorado 80220 —
Nemours Alfred I. duPont Hospital for Children Wilmington Delaware 19803 —
Children's National Hospital-George Washington University School of Medicine and Health Sciences Washington D.C. District of Columbia 20010-2970 —
Blood and Marrow Transplant Program, Johns Hopkins All Children's Hospital St. Petersburg Florida 33701 —
Aflac Cancer and Blood Disorders Center, Emory/Children's Healthcare of Atlanta Atlanta Georgia 30322 —
Ann & Robert H. Lurie Children's Hospital of Chicago Chicago Illinois 60614 —
Center for Cancer and Blood Disorders, Children's Hospital/Louisiana State University New Orleans Louisiana 70118 —
Boston Children's Hospital Boston Massachusetts 02115 —
Department of Pediatrics, C. S. Mott Children's Hospital, University of Michigan Ann Arbor Michigan 48109 —
Division of Pediatric Blood and Marrow Transplantation, University of Minnesota Minneapolis Minnesota 55455 —
Mayo Clinic Children's Center Rochester Minnesota 55905 —
Cardinal Glennon Children's Hospital, Saint Louis University St Louis Missouri 63104 —
Saint Louis Children's Hospital, Washington University St Louis Missouri 63110 —
Institute for Pediatric Cancer and Blood Disorders, Hackensack University Medical Center Hackensack New Jersey 07601 —
Department of Pediatrics, Memorial Sloan Kettering Cancer Center New York New York 10065 —
Department of Pediatrics, Golisano Children's Hospital, University of Rochester Rochester New York 14642 —
Maria Fareri Children's Hospital, New York Medical College Valhalla New York 10595 —
Duke University Medical Center Durham North Carolina 27710 —
Cincinnati Children's Hospital Medical Center, University of Cincinnati Cincinnati Ohio 45229-3039 —
Rainbow Babies and Children's Hospital Cleveland Ohio 44106 —
Nationwide Children's Hospital Columbus Ohio 43205 —
Division of Pediatric Hematology/Oncology, Oregon Health and Science University Portland Oregon 97239 —
Children's Hospital of Philadelphia, University of Pennsylvania Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 —
University of Pittsburgh Children's Hospital of Pittsburgh Pittsburgh Pennsylvania 15224 —
St. Jude Children's Research Hospital Memphis Tennessee 38105 —
Pediatrics, University of Texas Southwestern Medical Center Dallas Texas 75390-9263 —
Baylor College of Medicine Section of Immunology, Allergy, and Retrovirology, Texas Children's Hospital Houston Texas 77030-2399 —
Texas Transplant Institute, Methodist Children's Hospital San Antonio Texas 78229 —
Primary Children's Hospital, University of Utah Salt Lake City Utah 84113 —
Fred Hutchinson Cancer Research Center and University of Washington-Seattle Children's Hospital Seattle Washington 98109 —
American Family Children's Hospital, University of Wisconsin Madison Wisconsin 53705-2275 —
Children's Hospital of Wisconsin-Milwaukee Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02064933, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 10, 2020 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02064933 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →